World Health Organization, “Chronic obstructive pulmonary disease (COPD),” 6 November 2024.
“2025 Gold Report – Global Initiative for Chronic Obstructive Lung Disease.” GOLD, 17 Dec. 2024, goldcopd.org/2025-gold-report/.
Garudadri, Suresh, and Prescott G Woodruff. “Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers.” Annals of the American Thoracic Society vol. 15, Suppl 4 (2018): S234-S238. doi:10.1513/AnnalsATS.201808-533MG
Ho, Terence et al. “Under- and over-diagnosis of COPD: a global perspective.” Breathe (Sheffield, England) vol. 15,1 (2019): 24-35. doi:10.1183/2073
National Institute of Health, “Diagnosing and treating COPD: understanding the challenges and finding solutions” 28 October 2011
“COPD.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, www.cdc.gov/cdi/indicator-definitions/chronic-obstructive-pulmonary-disease.html.
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study. Chen, Simiao et al. The Lancet Global Health, Volume 11, Issue 8, e1183 – e1193
Minov, Jordan. (2024). Work Ability in Patients with COPD: Premature Retirement Summary. 10.46998/IJCMCR.2024.42.001028.
Choudhuri, Anirban Hom. “Palliative Care for Patients with Chronic Obstructive Pulmonary Disease: Current Perspectives.” Indian Journal of Palliative Care, U.S. National Library of Medicine, Jan. 2012, pmc.ncbi.nlm.nih.gov/articles/PMC3401737/.
Bakthavatsalu, Barathi, et al. “The Experience of Hospitalization in People with Advanced Chronic Obstructive Pulmonary Disease: A Qualitative, Phenomenological Study.” Chronic Illness, U.S. National Library of Medicine, June 2023, pmc.ncbi.nlm.nih.gov/articles/PMC9999271/.
May, Sara M, and James T C Li. “Burden of chronic obstructive pulmonary disease: healthcare costs and beyond.” Allergy and asthma proceedings vol. 36,1 (2015): 4-10. doi:10.2500/aap.2015.36.3812
“COPD Index.” COPD Index, Copenhagen Institute for Future Studies, respiratoryhealth.org/copd.
Respiratory Medicine, “Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review,” August 2023.
Lindgren, Sari et al. “Living in negotiation: patients’ experiences of being in the diagnostic process of COPD.” International journal of chronic obstructive pulmonary disease vol. 9 441-51. 6 May. 2014, doi:10.2147/COPD.S60182 https://pmc.ncbi.nlm.nih.gov/articles/PMC4018318/#sec19
Stigma: An Unmet Public Health Priority in COPD – the Lancet Respiratory Medicine, The Lancet Respiratory Medicine, Sept. 2021, www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00316-7/fulltext.
Johns, David P, et al. “Diagnosis and Early Detection of COPD Using Spirometry.” Journal of Thoracic Disease, U.S. National Library of Medicine, Nov. 2014.
Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease | American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory and Critical Care Medicine, 12 Apr. 2018, www.atsjournals.org/doi/10.1164/rccm.201804-0621CI.
Vogelmeier, Claus F, et al. Goals of COPD Treatment: Focus on Symptoms and Exacerbations, U.S. National Library of Medicine, 21 Mar. 2020, pubmed.ncbi.nlm.nih.gov/32250871/.
Cazzola, Mario et al. “Novel Anti-Inflammatory Approaches to COPD.” International journal of chronic obstructive pulmonary disease vol. 18 1333-1352. 29 Jun. 2023, doi:10.2147/COPD.S419056
Sun Y, Zhou J. New insights into early intervention of chronic obstructive pulmonary disease with mild airflow limitation. Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1119-1125. doi: 10.2147/COPD.S205382. PMID: 31213792; PMCID: PMC6536809.
Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011; 66(7): 585-90 https://pubmed.ncbi.nlm.nih.gov/21515553.
Suissa, S., Dell’Aniello, S. & Ernst, P., “Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality,” Thorax, Vol. 67(11), pp. 957-963, November 2012. doi: 10.1136/thoraxjnl-2011-201518. Epub: 8 June 2012. PMID: 22684094; PMCID: PMC3505864.
Barnes, P. J. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology, 138(1), 2016, 16-27
Gershon, A.S., Thiruchelvam, D., Aaron, S., Stanbrook, M., Vozoris, N., Tan, W.C, Cho, E. & To, T., “Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: A population-based cohort study,” PLoS ONE, 14(5): e0216741, 21 May 2019. https://doi.org/10.1371/journal.pone.0216741
Mannino, David M et al. “National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.” Chest vol. 165,5 (2024): 1093-1106. doi:10.1016/j.chest.2023.11.040
American Journal of Respiratory and Critical Care Medicine, “Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study,” 1 July 2023.
Park, J-E., et al. “Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study.” Value in Health Regional Issues, vol. 32, Nov. 2022, pp. 8–16. https://doi.org/10.1016/j.vhri.2022.06.002.
van Helvoort, Hanneke Ac et al. “Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study.” NPJ primary care respiratory medicine vol. 26 16054. 13 Oct. 2016, doi:10.1038/npjpcrm.2016.54
de Sousa Sena, Riany et al. “Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.” The European respiratory journal vol. 50,3 1701154. 12 Sep. 2017, doi:10.1183/13993003.01154-2017
link